March 26 (Reuters) - Avalo Therapeutics Inc AVTX.O:
AVALO THERAPEUTICS APPOINTS MICHAEL HEFFERNAN AS CHAIRMAN OF THE BOARD
AVALO THERAPEUTICS - GARRY NEIL TO REMAIN AS CEO AND BOARD MEMBER
Source text: ID:nGNX8mG9R
Further company coverage: AVTX.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.